Literature DB >> 18295638

Heterotopic ossification as an unusual complication after Guillain-Barré syndrome: a case report.

Su-Ra Ryu1, Jae-Hyung Kim, In-Sung Choi, Jae-Young Han, Sam-Gyu Lee.   

Abstract

Heterotopic ossification (HO) is the abnormal development of bone within soft tissue. It is frequently encountered after traumatic brain injury or spinal cord injury, rather than lower motoneuron disease. It has been reported as a rare complication in Guillain-Barré syndrome (GBS). We present the case of a 31-year-old woman who suffered from pain and swelling with limitation of the passive range of motion on right hip joint, and who had been diagnosed with GBS about 1 year previously. She was wheelchair-bound and had incomplete tetraplegia with flaccidity. She was diagnosed as HO based on the radiologic imaging study. She did not reveal any encephalopathy-related symptoms or signs, and hypercalcemia, and/or related metabolic derangement during 1.5-year follow-up period. Owing to the paucity of other causative factors, we presumed that the long-time hypomobility, even though not accompanied by hypercalcemia, played a major role for the development of HO. Early active rehabilitative management was initiated. The outcome is not promising because of her long-standing paralyzed state; however, it was possible to prevent the aggravation of HO.

Entities:  

Mesh:

Year:  2008        PMID: 18295638     DOI: 10.1016/j.apmr.2007.11.004

Source DB:  PubMed          Journal:  Arch Phys Med Rehabil        ISSN: 0003-9993            Impact factor:   3.966


  2 in total

Review 1.  [Neurogenic osteoarthritis in Guillain Barre syndrome: a rare complication (case report and review of the literature)].

Authors:  Hatim Abid; Mohamed El Idrissi; Mohamed Shimi; Abdelhalim El Ibrahimi; Abdelmajid El Mrini
Journal:  Pan Afr Med J       Date:  2015-03-13

2.  Neurogenic heterotopic ossification in Guillain-Barre syndrome: a rare case report.

Authors:  Mecbure Nalbantoglu; Ozlem Gungor Tuncer; M Eren Acık; Zeliha Matur; Burcu Altunrende; Ebru Ozgonenel; Levent Ozgonenel
Journal:  J Musculoskelet Neuronal Interact       Date:  2020-03-03       Impact factor: 2.041

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.